Your English writing platform
Discover LudwigExact(4)
Whichever statistic is used, IBD mapping focuses on signals from rare variants.
This widely used IBD model depends largely on MMP9 protease activity, as MMP9-deficient mice are resistant to DSS-induced colonic inflammation, 15 and MMP inhibition reduced clinical features.
Most of the currently used IBD treatments target the immune regulatory pathways, but resulting immunosuppression can increase patient risk for developing opportunistic infections and/or treatment-related lymphomas.
We have previously used IBD scale factors of 1 (Browning and Browning 2010) and 2 (B. L. Browning and S. R. Browning 2011).
Similar(56)
To determine whether the reduced phosphorylation level resulted in lower Aurora-B kinase activity, we used IB analysis to evaluate the phosphorylation status of MCAK, a known Aurora-B substrate.
We now demonstrate this biologic heterogeneity using IBs seeded by an identical polyQ repeat expressed in the context of different fluorescent protein tags.
We also observe that when threshold 10E-3 is used, IBD-Groupon achieves the same detection power as MCMC does, but it also suffers from false positives.
Our IBD-segment-based analyses with GCTA are similar to the work of Price et al. (2011) which used IBD-segment-based estimates of relatedness in a variance component approach to estimating heritability, although Price et al. focused on closely related pairs of individuals.
Secondary antibodies used for IB were: (1∶10000) horseradish peroxidase-linked anti-mouse or anti-rabbit (Chemicon).
Four decoy structures were used: profilin IB, ketosteroid isomerase, a VH domain, and human bromodomain.
We used immunoblotting (IB) as the basis of our serodiagnostic method due to its simplicity and sensitivity (18- 20).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com